GlaxoSmithKline fights IRS on $680 million assessment

Pharmaceuticals company faces court battles with revenue authorities
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: